Vertex Pharmaceuticals Inc. buy geldnutzer
Start price
22.10.20
/
50%
€177.98
Target price
04.11.21
€170.00
Performance (%)
-6.03%
End price
05.11.21
€167.24
Summary
This prediction ended on 05.11.21 with a price of €167.24. With a performance of -6.03%, the BUY prediction for Vertex Pharmaceuticals Inc. by geldnutzer closed slightly in the red. geldnutzer has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 5.368% | 5.368% | 23.188% | 123.831% |
| iShares Core DAX® | 4.094% | 3.543% | 17.404% | 20.326% |
| iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% | 55.365% |
| iShares Nikkei 225® | -1.572% | -4.633% | 15.731% | 2.146% |
| iShares S&P 500 | 1.822% | 0.963% | 30.396% | 45.950% |
According to geldnutzer what are the pros and cons of Vertex Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
positive Cash Flow expected
Good rating
High Investments for future growth
Very valuable balance sheet
ROE higher than 15% per year
Small challenges to pay loans and raise capital
Good culture
Capable Management
Strong uniques
Very differentiated customer and product portfolio
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Small cyclical dependencies
Undervalued
Leading role in innovation
Growths much faster than the competition
Well known brand
Very Future proof/growth oriented business model
Cons
Comments by geldnutzer for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 210,0
Kursziel geändert auf 200,0
Kursziel geändert auf 210,0
Kursziel geändert auf 180,0
Kursziel geändert auf 190,0
Kursziel geändert auf 170,0
In the thread Trading Vertex Pharmaceuticals Inc.
Die von geldnutzer gewählte maximale Laufzeit wurde überschritten